Yan He

Tongji Medical College

H指数:22

被引数:2,595

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Remodeling the Host Immune Microenvironment in Carbapenem-Resistant Klebsiella pneumoniae: An Evidence-Graded Framework for Host-Directed Intervention

重塑产碳青霉烯酶肺炎克雷伯菌宿主免疫微环境：基于证据分级的宿主导向干预框架

International Journal of Antimicrobial Agents

IF4.6

2026-09-060

OAAI

Real-World Effectiveness of Ceftazidime–Avibactam for Multidrug-Resistant Gram-Negative Pneumonia, Time-Stratified Risk Factors for Short- and Long-Term Mortality, and Inpatient Costs: A Multicenter Retrospective Cohort Study

美罗培南-阿维巴坦治疗多重耐药革兰阴性菌肺炎的真实世界效果，短期和长期死亡率的分层时间风险因素及住院费用：一项多中心回顾性队列研究

Infectious Diseases and Therapy

IF5.3

2026-07-280

Real-World Clinical Outcomes of Sulbactam-Durlobactam Against Carbapenem-Resistant Acinetobacter baumannii with Diverse β-Lactamase Profiles: A Multicenter Study in China

中国多中心研究：舒巴坦-多洛罗巴坦治疗不同β-内酰胺酶表型的碳青霉烯耐药鲍曼不动杆菌的真实世界临床疗效

Infection and Drug Resistance

IF2.9

2026-07-230

OAAI

Asperiecolins A–D: Undescribed Variecolin-Type Sesterterpenoids with Anti-Inflammatory and AChE Inhibitory Activities from Aspergillus sp. TJ403-YJ22

Asperiecolins A–D：来自Aspergillus sp. TJ403-YJ22的未描述的Variecolin型倍半萜类化合物，具有抗炎和AChE抑制活性

The Journal of Organic Chemistry

IF3.6

2026-04-150

PRE

Isavuconazole in Pediatric Invasive Fungal Infections: Outcomes and Therapeutic Drug Monitoring in a Chinese Multicenter Case Series

伊曲康唑在中国多中心病例系列中的儿科侵袭性真菌感染：结局与治疗药物监测

Infection and Drug Resistance

IF2.9

2026-04-130

OAAI

In vitro study on reversible regulation of CAR-T function by Kinsenoside

体外研究Kinsenoside对CAR-T功能的可逆调节

Molecular Biology Reports

IF2.8

2025-10-210

Discovery of natural CdnP inhibitors through structure-based virtual screening and molecular dynamics simulations

基于结构的虚拟筛选和分子动力学模拟发现天然CdnP抑制剂

MICROBIOLOGY SPECTRUM

IF3.8

2025-06-030

Omadacycline for Diverse Infections in China: A Real-World Analysis of Efficacy and Safety

奥马珠单抗在中国多种感染中的应用：一项真实世界疗效与安全性分析

Infectious Diseases and Therapy

IF5.3

2024-10-220

OAAI

Real-World, Multicenter Case Series of Patients Treated with Isavuconazole for Invasive Fungal Disease in China

MICROORGANISMS

IF4.2

2023-09-042

OAAI

Emerione A, a novel fungal metabolite as an inhibitor of New Delhi metallo-β-lactamase 1, restores carbapenem susceptibility in carbapenem-resistant isolates

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE

IF3.2

2022-03-0112

OAAI

Zinc enzymes in medicinal chemistry

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2021-12-0125

PRE

Residents' Willingness to Maintain Contracts with Family Doctors: a Cross-sectional Study in China

JOURNAL OF GENERAL INTERNAL MEDICINE

IF4.2

2020-11-0230

OAAI

Bioassay-Directed Isolation of Antibacterial Metabolites from an Arthropod-Derived Penicillium chrysogenum

JOURNAL OF NATURAL PRODUCTS

IF3.6

2020-10-2218

PREAI

Multiple organ injury on admission predicts in-hospital mortality in patients with COVID-19

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2020-09-305

OAAI

Structurally diverse and bioactive alkaloids from an insect-derived fungus Neosartorya fischeri

PHYTOCHEMISTRY

IF3.4

2020-07-0114

PREAI

Novel Antimicrobial Compounds as Ophiobolin-Type Sesterterpenes and Pimarane-Type Diterpene From Bipolaris Species TJ403-B1

FRONTIERS IN MICROBIOLOGY

IF4.5

2020-05-2911

OAAI

Challenges and strategies to research ethics in conducting COVID-19 research

bmj evidence based medicine

IF3.5

2020-05-2229

OAAI

Association between age and clinical characteristics and outcomes of COVID-19

EUROPEAN RESPIRATORY JOURNAL

IF21

2020-04-20301

OAAI

Nosocomial infection among patients with COVID-19: A retrospective data analysis of 918 cases from a single center in Wuhan, China

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

IF3

2020-04-1378

Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2020-03-31616

OAAI

Yan He

个人简介

教育背景

工作经历

荣誉奖项

研究方向